uk 68798 has been researched along with Adverse Drug Event in 10 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (10.00) | 29.6817 |
2010's | 8 (80.00) | 24.3611 |
2020's | 1 (10.00) | 2.80 |
Authors | Studies |
---|---|
Ding, D; Fang, H; Kelly, R; Liu, Z; Shi, Q; Tong, W | 1 |
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Hondeghem, LM | 1 |
Dick, T; Negrelli, J; Olson, JL; Rickard, JP | 1 |
Benson, C; Brown, R; Couderc, JP; Darpo, B; Dota, C; Ferber, G; Ferry, J; Jarugula, V; Keirns, J; Ortemann-Renon, C; Pham, T; Riley, S; Sarapa, N; Ticktin, M; Zareba, W | 1 |
Agusala, K; Caprio, T; Kulkarni, C; Oesterle, A; Passman, R; Subacius, H | 1 |
Dietrich, NM; Franck, AJ; Kaufmann, MR; McKillop, M; Panna, M; Quffa, LH | 1 |
Shah, Y; Steinberg, JS; Szepietowska, B | 1 |
Thomsen, MB | 1 |
1 trial(s) available for uk 68798 and Adverse Drug Event
Article | Year |
---|---|
Evaluation of the Effect of 5 QT-Positive Drugs on the JTpeak Interval - An Analysis of ECGs From the IQ-CSRC Study.
Topics: Arrhythmias, Cardiac; Biomarkers; Cetirizine; Drug-Related Side Effects and Adverse Reactions; Electrocardiography; Female; Fluoroquinolones; Healthy Volunteers; Heart Conduction System; Heart Rate; Humans; Indoles; Ion Channels; Long QT Syndrome; Male; Moxifloxacin; Ondansetron; Phenethylamines; Quinine; Quinolizines; Risk Assessment; Sulfonamides | 2020 |
9 other study(ies) available for uk 68798 and Adverse Drug Event
Article | Year |
---|---|
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
Topics: Animals; Anti-Infective Agents; Anti-Inflammatory Agents; Chemical and Drug Induced Liver Injury; Databases, Factual; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Models, Biological; Predictive Value of Tests | 2011 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Drug-Induced QT Prolongation and Torsades de Pointes: An All-Exclusive Relationship or Time for an Amicable Separation?
Topics: Anti-Arrhythmia Agents; Cardiotonic Agents; Cnidarian Venoms; Drug-Related Side Effects and Adverse Reactions; False Positive Reactions; Humans; Long QT Syndrome; Phenethylamines; Sulfonamides; Torsades de Pointes | 2018 |
Frequency of Adverse Event Monitoring in Ambulatory Patients on Amiodarone or Dofetilide.
Topics: Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Cohort Studies; Drug Monitoring; Drug-Related Side Effects and Adverse Reactions; Female; Follow-Up Studies; Humans; Male; Middle Aged; Phenethylamines; Retrospective Studies; Sulfonamides | 2018 |
Risk prediction for adverse events during initiation of sotalol and dofetilide for the treatment of atrial fibrillation.
Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Comorbidity; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Illinois; Long QT Syndrome; Male; Middle Aged; Phenethylamines; Prevalence; Retrospective Studies; Risk Factors; Sotalol; Sulfonamides; Treatment Outcome; Ventricular Fibrillation | 2015 |
Impact of a Pharmacy-Cardiology Collaborative Practice on Dofetilide Safety Monitoring.
Topics: Aged; Anti-Arrhythmia Agents; Cardiologists; Drug Interactions; Drug Monitoring; Drug-Related Side Effects and Adverse Reactions; Electrocardiography; Female; Hospitalization; Humans; Intersectoral Collaboration; Male; Medication Adherence; Middle Aged; Pharmacists; Phenethylamines; Retrospective Studies; Sulfonamides | 2017 |
Pharmacologic Conversion during Dofetilide Treatment for Persistent Atrial Fibrillation.
Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Causality; Chronic Disease; Cohort Studies; Comorbidity; Drug-Related Side Effects and Adverse Reactions; Electrocardiography; Female; Humans; Long QT Syndrome; Male; Middle Aged; New York; Phenethylamines; Retrospective Studies; Risk Factors; Sulfonamides; Torsades de Pointes; Treatment Outcome | 2017 |
Double pharmacological challenge on repolarization opens new avenues for drug safety research.
Topics: Animals; Chromans; Delayed Rectifier Potassium Channels; Dogs; Drug Synergism; Drug-Related Side Effects and Adverse Reactions; Electrocardiography; Humans; Long QT Syndrome; Phenethylamines; Potassium Channel Blockers; Potassium Channels, Voltage-Gated; Rabbits; Risk Factors; Sulfonamides; Torsades de Pointes | 2007 |